Unilateral injection of 6-hydroxydopamine (6-OHDA) is commonly used to generate a rodent model of Parkinson’s disease (PD). Although motor deficits of the lower extremities represent one of the major clinical symptoms in PD patients, validated tests for assessing motor impairments of the hind limb in 6-OHDA mice are currently unavailable. We here report the video-based assessments of the asymmetric use of hind limbs in 6-OHDA mice. A significantly decreased number of spontaneous hind limb stepping was observed in the contralateral-to-lesioned side, and was dose dependently reversed by levodopa, suggesting that it could be utilized for screening PD therapeutics
Parkinson’s disease (PD) is the 2nd most common neurodegenerative disorder due to gradual loss of do...
Dyskinesia (abnormal involuntary movements) is a common complication of l-DOPA pharmacotherapy in Pa...
Gait disturbances and postural instability represent major sources of morbidity in Parkinson's disea...
Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by mar...
Unilateral 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal pathway produce side-biased motor...
6-Hydroxydopamine (6-OHDA) lesions are being used in the mouse for basic research on Parkinson's dis...
Parkinson’s disease (PD) is a debilitating disorder that is likely to reach pandemic proportions by ...
The most frequently used animal models for Parkinson's disease (PD) utilize unilateral injection of ...
Parkinson’s disease (PD) is the most common neurodegenerative motor disorder and primarily affects m...
Parkinson's disease (PD) is an age-associated neurodegenerative disorder hallmarked by a loss of mes...
Animal models of Parkinson’s disease and L-DOPA-induced dyskinesia are essential to explore pathophy...
Objective : The aim of this study was to investigate voluntary wheel running behavior in the unilate...
Unilateral 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal pathway produce side-biased motor...
IntroductionDespite the widespread use of the unilateral striatal 6-hydroxydopamine (6-OHDA) lesion ...
Parkinson's disease is most commonly modelled via unilateral infusion of the neurotoxin 6-hydroxydop...
Parkinson’s disease (PD) is the 2nd most common neurodegenerative disorder due to gradual loss of do...
Dyskinesia (abnormal involuntary movements) is a common complication of l-DOPA pharmacotherapy in Pa...
Gait disturbances and postural instability represent major sources of morbidity in Parkinson's disea...
Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by mar...
Unilateral 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal pathway produce side-biased motor...
6-Hydroxydopamine (6-OHDA) lesions are being used in the mouse for basic research on Parkinson's dis...
Parkinson’s disease (PD) is a debilitating disorder that is likely to reach pandemic proportions by ...
The most frequently used animal models for Parkinson's disease (PD) utilize unilateral injection of ...
Parkinson’s disease (PD) is the most common neurodegenerative motor disorder and primarily affects m...
Parkinson's disease (PD) is an age-associated neurodegenerative disorder hallmarked by a loss of mes...
Animal models of Parkinson’s disease and L-DOPA-induced dyskinesia are essential to explore pathophy...
Objective : The aim of this study was to investigate voluntary wheel running behavior in the unilate...
Unilateral 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal pathway produce side-biased motor...
IntroductionDespite the widespread use of the unilateral striatal 6-hydroxydopamine (6-OHDA) lesion ...
Parkinson's disease is most commonly modelled via unilateral infusion of the neurotoxin 6-hydroxydop...
Parkinson’s disease (PD) is the 2nd most common neurodegenerative disorder due to gradual loss of do...
Dyskinesia (abnormal involuntary movements) is a common complication of l-DOPA pharmacotherapy in Pa...
Gait disturbances and postural instability represent major sources of morbidity in Parkinson's disea...